Trinity Historical Balance Sheet

TRIB Stock

USD 0.64 0.03 4.48%

Trend analysis of Trinity Biotech plc balance sheet accounts such as Property Plant And Equipment Net of 2.1 M, Net Debt of 77 M, Accounts Payable of 4.2 M or Cash of 4 M provides information on Trinity Biotech's total assets, liabilities, and equity, which is the actual value of Trinity Biotech plc to its prevalent stockholders. By breaking down trends over time using Trinity Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Trinity Biotech plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Trinity Biotech plc is a good buy for the upcoming year.

Trinity Biotech Inventory

25.53 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trinity Biotech plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Trinity Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Trinity Biotech plc at a specified time, usually calculated after every quarter, six months, or one year. Trinity Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Trinity Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Trinity currently owns. An asset can also be divided into two categories, current and non-current.

Trinity Biotech Balance Sheet Chart

At present, Trinity Biotech's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 22.6 M, whereas Total Assets are forecasted to decline to about 64.9 M.

Total Assets Short Long Term Debt Total Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of Trinity Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Trinity Biotech plc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Trinity Biotech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Trinity Biotech plc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from Trinity Biotech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Trinity Biotech plc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trinity Biotech plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	58.3M	67.4M	77.5M	42.8M
Total Assets	92.1M	59.4M	68.4M	64.9M

Short Long Term Debt Total Total Assets

Trinity Biotech balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Property Plant And Equipment Gross	Common Stock
Total Assets		0.53	-0.17	0.03	0.87	0.93	-0.48	0.87	0.82	0.78	0.94	0.88	0.78	0.73	-0.58	0.24	0.69	-0.03	-0.39	0.3	0.86	-0.05	0.94	0.42	-0.52	-0.29
Short Long Term Debt Total	0.53		0.13	0.36	0.21	0.51	0.23	0.24	0.56	0.21	0.52	0.42	0.21	0.53	-0.1	0.45	0.79	-0.09	-0.23	0.64	0.4	0.25	0.53	0.68	-0.12	0.04
Other Current Liab	-0.17	0.13		0.17	-0.03	-0.05	0.08	-0.06	-0.36	-0.46	0.01	-0.01	-0.46	-0.08	0.64	-0.35	-0.01	-0.15	0.11	-0.31	-0.35	0.24	0.0	0.22	0.54	0.49
Total Current Liabilities	0.03	0.36	0.17		-0.16	0.03	0.33	-0.08	-0.06	-0.01	-0.01	-0.13	-0.01	0.07	0.2	-0.11	0.33	-0.07	-0.38	0.36	0.08	0.96	-0.03	0.27	0.32	0.01
Total Stockholder Equity	0.87	0.21	-0.03	-0.16		0.83	-0.82	0.99	0.68	0.67	0.88	0.92	0.67	0.51	-0.65	-0.21	0.33	-0.01	-0.4	-0.2	0.65	-0.11	0.85	0.13	-0.59	-0.44
Property Plant And Equipment Net	0.93	0.51	-0.05	0.03	0.83		-0.42	0.85	0.75	0.57	0.96	0.78	0.57	0.67	-0.53	0.17	0.63	0.1	-0.3	0.24	0.67	-0.02	0.94	0.34	-0.49	-0.33
Net Debt	-0.48	0.23	0.08	0.33	-0.82	-0.42		-0.81	-0.32	-0.55	-0.46	-0.64	-0.55	-0.08	0.61	0.56	0.21	0.0	0.37	0.61	-0.37	0.19	-0.42	0.24	0.56	0.52
Retained Earnings	0.87	0.24	-0.06	-0.08	0.99	0.85	-0.81		0.68	0.68	0.87	0.89	0.68	0.52	-0.69	-0.23	0.33	0.02	-0.49	-0.18	0.66	-0.04	0.83	0.11	-0.64	-0.52
Accounts Payable	0.82	0.56	-0.36	-0.06	0.68	0.75	-0.32	0.68		0.55	0.79	0.82	0.55	0.75	-0.7	0.31	0.71	0.03	-0.32	0.33	0.68	-0.15	0.78	0.41	-0.62	-0.34
Cash	0.78	0.21	-0.46	-0.01	0.67	0.57	-0.55	0.68	0.55		0.55	0.61	1.0	0.44	-0.57	0.22	0.35	-0.12	-0.51	0.25	0.93	-0.1	0.55	0.19	-0.51	-0.35
Non Current Assets Total	0.94	0.52	0.01	-0.01	0.88	0.96	-0.46	0.87	0.79	0.55		0.89	0.55	0.66	-0.52	0.12	0.63	-0.01	-0.27	0.17	0.66	-0.04	0.99	0.35	-0.46	-0.28
Non Currrent Assets Other	0.88	0.42	-0.01	-0.13	0.92	0.78	-0.64	0.89	0.82	0.61	0.89		0.61	0.6	-0.61	-0.04	0.5	-0.13	-0.39	-0.04	0.66	-0.13	0.88	0.29	-0.56	-0.32
Cash And Short Term Investments	0.78	0.21	-0.46	-0.01	0.67	0.57	-0.55	0.68	0.55	1.0	0.55	0.61		0.44	-0.57	0.22	0.35	-0.12	-0.51	0.25	0.93	-0.1	0.55	0.19	-0.51	-0.35
Net Receivables	0.73	0.53	-0.08	0.07	0.51	0.67	-0.08	0.52	0.75	0.44	0.66	0.6	0.44		-0.34	0.42	0.88	0.2	-0.25	0.44	0.71	-0.1	0.65	0.67	-0.37	0.0
Common Stock Shares Outstanding	-0.58	-0.1	0.64	0.2	-0.65	-0.53	0.61	-0.69	-0.7	-0.57	-0.52	-0.61	-0.57	-0.34		0.09	-0.14	-0.09	0.52	0.07	-0.47	0.16	-0.48	0.22	0.95	0.87
Non Current Liabilities Total	0.24	0.45	-0.35	-0.11	-0.21	0.17	0.56	-0.23	0.31	0.22	0.12	-0.04	0.22	0.42	0.09		0.58	-0.03	0.23	0.86	0.39	-0.36	0.18	0.46	0.03	0.34
Inventory	0.69	0.79	-0.01	0.33	0.33	0.63	0.21	0.33	0.71	0.35	0.63	0.5	0.35	0.88	-0.14	0.58		0.02	-0.19	0.7	0.65	0.14	0.64	0.79	-0.12	0.17
Other Current Assets	-0.03	-0.09	-0.15	-0.07	-0.01	0.1	0.0	0.02	0.03	-0.12	-0.01	-0.13	-0.12	0.2	-0.09	-0.03	0.02		0.42	-0.06	-0.06	-0.05	-0.04	0.04	-0.06	-0.01
Other Stockholder Equity	-0.39	-0.23	0.11	-0.38	-0.4	-0.3	0.37	-0.49	-0.32	-0.51	-0.27	-0.39	-0.51	-0.25	0.52	0.23	-0.19	0.42		-0.02	-0.45	-0.38	-0.22	0.05	0.54	0.62
Total Liab	0.3	0.64	-0.31	0.36	-0.2	0.24	0.61	-0.18	0.33	0.25	0.17	-0.04	0.25	0.44	0.07	0.86	0.7	-0.06	-0.02		0.42	0.12	0.2	0.6	0.07	0.2
Total Current Assets	0.86	0.4	-0.35	0.08	0.65	0.67	-0.37	0.66	0.68	0.93	0.66	0.66	0.93	0.71	-0.47	0.39	0.65	-0.06	-0.45	0.42		-0.07	0.66	0.42	-0.43	-0.17
Short Term Debt	-0.05	0.25	0.24	0.96	-0.11	-0.02	0.19	-0.04	-0.15	-0.1	-0.04	-0.13	-0.1	-0.1	0.16	-0.36	0.14	-0.05	-0.38	0.12	-0.07		-0.07	0.12	0.29	-0.1
Intangible Assets	0.94	0.53	0.0	-0.03	0.85	0.94	-0.42	0.83	0.78	0.55	0.99	0.88	0.55	0.65	-0.48	0.18	0.64	-0.04	-0.22	0.2	0.66	-0.07		0.37	-0.41	-0.22
Common Stock Total Equity	0.42	0.68	0.22	0.27	0.13	0.34	0.24	0.11	0.41	0.19	0.35	0.29	0.19	0.67	0.22	0.46	0.79	0.04	0.05	0.6	0.42	0.12	0.37		0.2	0.48
Property Plant And Equipment Gross	-0.52	-0.12	0.54	0.32	-0.59	-0.49	0.56	-0.64	-0.62	-0.51	-0.46	-0.56	-0.51	-0.37	0.95	0.03	-0.12	-0.06	0.54	0.07	-0.43	0.29	-0.41	0.2		0.85
Common Stock	-0.29	0.04	0.49	0.01	-0.44	-0.33	0.52	-0.52	-0.34	-0.35	-0.28	-0.32	-0.35	0.0	0.87	0.34	0.17	-0.01	0.62	0.2	-0.17	-0.1	-0.22	0.48	0.85

Click cells to compare fundamentals

Trinity Biotech Account Relationship Matchups

Trinity Biotech balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	130.4M	118.9M	92.1M	59.4M	68.4M	64.9M
Short Long Term Debt Total	104.3M	99.2M	58.3M	67.4M	77.5M	42.8M
Other Current Liab	9.6M	7.9M	9.1M	8.9M	10.3M	10.8M
Total Current Liabilities	27.1M	100.5M	17.3M	15.0M	17.3M	22.6M
Total Stockholder Equity	(2.2M)	(319K)	(2.2M)	(23.9M)	(27.5M)	(26.2M)
Property Plant And Equipment Net	8.5M	5.9M	5.7M	1.9M	2.2M	2.1M
Net Debt	77.0M	73.2M	51.7M	63.7M	73.3M	77.0M
Retained Earnings	10.6M	12.6M	(26.7M)	(48.6M)	(55.9M)	(53.1M)
Accounts Payable	7.1M	6.8M	6.2M	3.9M	4.5M	4.2M
Cash	27.3M	25.9M	6.6M	3.7M	4.2M	4.0M
Non Current Assets Total	47.1M	46.2M	45.4M	20.4M	23.5M	22.3M
Non Currrent Assets Other	64K	56K	55K	43K	38.7K	36.8K
Cash And Short Term Investments	27.3M	25.9M	6.6M	3.7M	4.2M	4.0M
Net Receivables	24.6M	15.7M	13.4M	13.4M	15.4M	18.1M
Common Stock Shares Outstanding	83.6M	106.5M	155.5M	153.1M	176.1M	184.9M
Liabilities And Stockholders Equity	130.4M	118.9M	92.1M	59.4M	68.4M	64.9M
Non Current Liabilities Total	105.6M	18.7M	76.9M	68.3M	78.6M	82.5M
Inventory	30.2M	29.1M	22.5M	19.9M	22.9M	25.5M
Other Current Assets	1.2M	1.9M	4.1M	2.0M	2.3M	3.9M
Total Liab	132.6M	119.2M	94.3M	83.4M	95.9M	61.7M
Total Current Assets	83.3M	72.7M	46.7M	39.0M	44.9M	69.5M
Short Term Debt	5.1M	85.3M	1.9M	1.9M	2.2M	2.1M
Intangible Assets	21.3M	23.4M	22.7M	16.3M	18.7M	17.8M
Property Plant And Equipment Gross	8.5M	63.5M	65.6M	66.1M	76.0M	79.8M
Accumulated Other Comprehensive Income	(5.3M)	(5.4M)	(5.7M)	1.0M	1.2M	1.2M
Long Term Debt	82.0M	83.9M	58.0M	54.7M	62.8M	44.0M
Property Plant Equipment	5.4M	9.3M	8.5M	5.9M	5.3M	9.6M
Other Liab	8.1M	7.1M	6.3M	4.9M	5.6M	6.2M
Current Deferred Revenue	4.4M	141K	114K	50K	45K	42.8K
Other Assets	33.0M	29.5M	18.1M	4.3M	5.0M	4.7M
Net Tangible Assets	17.4M	(16.2M)	(22.6M)	(36.3M)	(32.7M)	(31.0M)
Deferred Long Term Liab	26.3M	22.8M	13.4M	17.7M	15.9M	15.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Trinity Biotech plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trinity Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trinity Biotech Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trinity Biotech Plc Stock:

How To Invest In Trinity

Details

Is Trinity Stock a good investment?

Details

What is Trinity Biotech's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.77)

Earnings Share

(2.25)

Revenue Per Share

6.497

Quarterly Revenue Growth

0.032

Return On Assets

(0.08)

The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Trinity Historical Balance Sheet

Trinity Biotech Inventory

25.53 Million

About Trinity Balance Sheet Analysis

Trinity Biotech Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Trinity Biotech balance sheet Correlations

Trinity Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Trinity Biotech balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Retained Earnings	+ 0.99	Total Stockholder Equity
Intangible Assets	+ 0.99	Non Current Assets Total
Short Term Debt	+ 0.96	Total Current Liabilities
Non Current Assets Total	+ 0.96	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.95	Common Stock Shares Outstanding

Net Debt	- 0.82	Total Stockholder Equity
Retained Earnings	- 0.81	Net Debt
Common Stock Shares Outstanding	- 0.7	Accounts Payable
Common Stock Shares Outstanding	- 0.69	Retained Earnings
Common Stock Shares Outstanding	- 0.65	Total Stockholder Equity
Property Plant And Equipment Gross	- 0.64	Retained Earnings